Monthly
US$200
Billed every month
Sign in to subscribeVancomycin Hydrochloride for Injection
Matched- Active ingredients (original)
- VANCOMYCIN HYDROCHLORIDE
- Dosage form (original)
- INJECTABLE
- Route (original)
- INJECTION
Read these limits
- US patent expiration does not establish Chinese patent expiration. Dates here come from the US Orange Book; Chinese patent status needs separate checking.
- The Orange Book lists holder-submitted patents and does not cover all related patents.
- “Unmatched” means no English ingredient-name counterpart in the Chinese official-name sources loaded here; it does not mean no Chinese approval or filing. A zero count means a Chinese name is matched but no records were found in the loaded source. Source dates appear below.
- This page contains no sales or market-size data and cannot establish development value.
- Names on unmatched rows are the original FDA Orange Book names, without Chinese translation. The same ingredient may have a different generic name in China.
US-approved products
Application numbers, product numbers and original fields are retained. Marketing status is shown as listed in the source.
Earliest approvalApproved before 1982
ANDA applications44
RLD applicant—
Currently marketed products: 49 · Counts FDA prescription and OTC marketing categories as listed; discontinued or unknown categories are excluded.
| Application / product number | Brand name (original) | Applicant (original) | Dosage form (original) | Route (original) | Strength (original) | Earliest approval | RLD / RS | Marketing status (original) | Official source |
|---|---|---|---|---|---|---|---|---|---|
| A060180-001 | VANCOCIN HYDROCHLORIDE | STERISCIENCE PTE LTD | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Approved before 1982 | N / N | DISCONTINUED | openFDA ↗ |
| A060180-002 | VANCOCIN HYDROCHLORIDE | STERISCIENCE PTE LTD | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 1986/03/21 | N / N | DISCONTINUED | openFDA ↗ |
| A062476-001 | VANCOCIN HYDROCHLORIDE | STERISCIENCE PTE LTD | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 500MG BASE/VIAL | 1984/03/15 | N / N | DISCONTINUED | openFDA ↗ |
| A062476-002 | VANCOCIN HYDROCHLORIDE | STERISCIENCE PTE LTD | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 1GM BASE/VIAL | 1986/03/21 | N / N | DISCONTINUED | openFDA ↗ |
| A062663-001 | VANCOMYCIN HYDROCHLORIDE | FRESENIUS KABI USA LLC | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 500MG BASE/VIAL | 1987/03/17 | N / Y | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A062663-002 | VANCOMYCIN HYDROCHLORIDE | FRESENIUS KABI USA LLC | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 1GM BASE/VIAL | 1987/07/31 | N / Y | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A062663-003 | VANCOMYCIN HYDROCHLORIDE | FRESENIUS KABI USA LLC | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 5GM BASE/VIAL | 1988/06/03 | N / Y | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A062663-004 | VANCOMYCIN HYDROCHLORIDE | FRESENIUS KABI USA LLC | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 10GM BASE/VIAL | 1997/11/28 | N / Y | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A062663-005 | VANCOMYCIN HYDROCHLORIDE | FRESENIUS KABI USA LLC | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 750MG BASE/VIAL | 2016/08/17 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A062682-001 | VANCOLED | HIKMA PHARMACEUTICALS USA INC | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 1986/07/22 | N / N | DISCONTINUED | openFDA ↗ |
| A062682-002 | VANCOLED | HIKMA PHARMACEUTICALS USA INC | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 1988/03/30 | N / N | DISCONTINUED | openFDA ↗ |
| A062682-003 | VANCOLED | HIKMA PHARMACEUTICALS USA INC | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 2GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 1988/05/11 | N / N | DISCONTINUED | openFDA ↗ |
| A062682-004 | VANCOLED | HIKMA PHARMACEUTICALS USA INC | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 5GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 1988/05/11 | N / N | DISCONTINUED | openFDA ↗ |
| A062682-005 | VANCOLED | HIKMA PHARMACEUTICALS USA INC | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 10GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 1988/05/11 | N / N | DISCONTINUED | openFDA ↗ |
| A062716-001 | VANCOCIN HYDROCHLORIDE | STERISCIENCE PTE LTD | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 500MG BASE/VIAL | 1987/03/13 | N / N | DISCONTINUED | openFDA ↗ |
| A062716-002 | VANCOCIN HYDROCHLORIDE | STERISCIENCE PTE LTD | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 1GM BASE/VIAL | 1987/03/13 | N / N | DISCONTINUED | openFDA ↗ |
| A062812-001 | VANCOCIN HYDROCHLORIDE | STERISCIENCE PTE LTD | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 1987/11/17 | N / N | DISCONTINUED | openFDA ↗ |
| A062812-002 | VANCOCIN HYDROCHLORIDE | STERISCIENCE PTE LTD | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 1987/11/17 | N / N | DISCONTINUED | openFDA ↗ |
| A062812-003 | VANCOCIN HYDROCHLORIDE | STERISCIENCE PTE LTD | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 10GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 1987/11/17 | N / N | DISCONTINUED | openFDA ↗ |
| A062879-001 | VANCOMYCIN HYDROCHLORIDE | HIKMA PHARMACEUTICALS USA INC | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 500MG BASE/VIAL | 1988/08/02 | N / N | DISCONTINUED | openFDA ↗ |
| A062879-002 | VANCOMYCIN HYDROCHLORIDE | HIKMA PHARMACEUTICALS USA INC | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 1GM BASE/VIAL | 1988/08/02 | N / N | DISCONTINUED | openFDA ↗ |
| A062911-001 | VANCOMYCIN HYDROCHLORIDE | HOSPIRA INC | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 500MG BASE/VIAL | 1988/08/04 | N / Y | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A062912-001 | VANCOMYCIN HYDROCHLORIDE | HOSPIRA INC | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 1GM BASE/VIAL | 1988/08/04 | N / Y | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A062912-002 | VANCOMYCIN HYDROCHLORIDE | HOSPIRA INC | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 750MG BASE/VIAL | 2009/01/07 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A062912-003 | VANCOMYCIN HYDROCHLORIDE | HOSPIRA INC | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 1.5GM BASE/VIAL | 2020/07/10 | N / Y | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A062931-001 | VANCOMYCIN HYDROCHLORIDE | HOSPIRA INC | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 500MG BASE/VIAL | 1992/10/29 | N / Y | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A062933-001 | VANCOMYCIN HYDROCHLORIDE | HOSPIRA INC | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 1GM BASE/VIAL | 1992/10/29 | N / Y | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A062933-002 | VANCOMYCIN HYDROCHLORIDE | HOSPIRA INC | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 750MG BASE/VIAL | 2009/05/27 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A062956-001 | VANCOR | PHARMACIA AND UPJOHN CO | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 500MG BASE/VIAL | 1988/08/01 | N / N | DISCONTINUED | openFDA ↗ |
| A062956-002 | VANCOR | PHARMACIA AND UPJOHN CO | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 1GM BASE/VIAL | 1988/08/01 | N / N | DISCONTINUED | openFDA ↗ |
| A063076-001 | VANCOMYCIN HYDROCHLORIDE | HOSPIRA INC | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 5GM BASE/VIAL | 1990/12/21 | N / Y | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A063076-002 | VANCOMYCIN HYDROCHLORIDE | HOSPIRA INC | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 10GM BASE/VIAL | 2020/09/14 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A065397-001 | VANCOMYCIN HYDROCHLORIDE | MYLAN LABORATORIES LTD | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 500MG BASE/VIAL | 2008/12/30 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A065397-002 | VANCOMYCIN HYDROCHLORIDE | MYLAN LABORATORIES LTD | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 1GM BASE/VIAL | 2008/12/30 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A065401-001 | VANCOMYCIN HYDROCHLORIDE | EUROFARMA INC | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 500MG BASE/VIAL | 2008/06/30 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A065401-002 | VANCOMYCIN HYDROCHLORIDE | EUROFARMA INC | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 1GM BASE/VIAL | 2008/06/30 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A065432-001 | VANCOMYCIN HYDROCHLORIDE | MYLAN LABORATORIES LTD | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 5GM BASE/VIAL | 2008/12/30 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A065455-001 | VANCOMYCIN HYDROCHLORIDE | HOSPIRA INC | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 10GM BASE/VIAL | 2009/04/29 | N / N | DISCONTINUED | openFDA ↗ |
| A090250-001 | VANCOMYCIN HYDROCHLORIDE | PLANO PHARMACEUTICALS INC | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 500MG BASE/VIAL | 2010/04/27 | N / N | DISCONTINUED | openFDA ↗ |
| A090250-002 | VANCOMYCIN HYDROCHLORIDE | PLANO PHARMACEUTICALS INC | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 1GM BASE/VIAL | 2010/04/27 | N / N | DISCONTINUED | openFDA ↗ |
| A091377-001 | VANCOMYCIN HYDROCHLORIDE | XELLIA PHARMACEUTICALS APS | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 500MG BASE/VIAL | 2015/09/09 | N / N | DISCONTINUED | openFDA ↗ |
| A091377-002 | VANCOMYCIN HYDROCHLORIDE | XELLIA PHARMACEUTICALS APS | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 1GM BASE/VIAL | 2015/09/09 | N / N | DISCONTINUED | openFDA ↗ |
| A091469-001 | VANCOMYCIN HYDROCHLORIDE | MYLAN LABORATORIES LTD | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 10GM BASE/VIAL | 2011/07/01 | N / N | DISCONTINUED | openFDA ↗ |
| A091554-001 | VANCOMYCIN HYDROCHLORIDE | MYLAN LABORATORIES LTD | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 10GM BASE/VIAL | 2011/09/19 | N / Y | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A200837-001 | VANCOMYCIN HYDROCHLORIDE | SAGENT PHARMACEUTICALS INC | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 5GM BASE/VIAL | 2012/08/10 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A200837-002 | VANCOMYCIN HYDROCHLORIDE | SAGENT PHARMACEUTICALS INC | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 10GM BASE/VIAL | 2014/09/02 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A201048-001 | VANCOMYCIN HYDROCHLORIDE | PLANO PHARMACEUTICALS INC | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 5GM BASE/VIAL | 2012/08/10 | N / N | DISCONTINUED | openFDA ↗ |
| A201048-002 | VANCOMYCIN HYDROCHLORIDE | PLANO PHARMACEUTICALS INC | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 10GM BASE/VIAL | 2012/08/10 | N / N | DISCONTINUED | openFDA ↗ |
| A201250-001 | VANCOMYCIN HYDROCHLORIDE | TEVA PHARMACEUTICALS USA | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 5GM BASE/VIAL | 2015/12/23 | N / N | DISCONTINUED | openFDA ↗ |
| A201250-002 | VANCOMYCIN HYDROCHLORIDE | TEVA PHARMACEUTICALS USA | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 10GM BASE/VIAL | 2015/12/23 | N / N | DISCONTINUED | openFDA ↗ |
| A201251-001 | VANCOMYCIN HYDROCHLORIDE | TEVA PHARMACEUTICALS USA | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 500MG BASE/VIAL | 2015/12/23 | N / N | DISCONTINUED | openFDA ↗ |
| A201251-002 | VANCOMYCIN HYDROCHLORIDE | TEVA PHARMACEUTICALS USA | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 1GM BASE/VIAL | 2015/12/23 | N / N | DISCONTINUED | openFDA ↗ |
| A202274-001 | VANCOMYCIN HYDROCHLORIDE | AVET LIFESCIENCES LTD | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 5GM BASE/VIAL | 2013/10/31 | N / N | DISCONTINUED | openFDA ↗ |
| A202275-001 | VANCOMYCIN HYDROCHLORIDE | AVET LIFESCIENCES LTD | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 500MG BASE/VIAL | 2013/10/31 | N / N | DISCONTINUED | openFDA ↗ |
| A202275-002 | VANCOMYCIN HYDROCHLORIDE | AVET LIFESCIENCES LTD | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 1GM BASE/VIAL | 2013/10/31 | N / N | DISCONTINUED | openFDA ↗ |
| A202464-001 | VANCOMYCIN HYDROCHLORIDE | AVET LIFESCIENCES LTD | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 10GM BASE/VIAL | 2013/10/09 | N / N | DISCONTINUED | openFDA ↗ |
| A203300-001 | VANCOMYCIN HYDROCHLORIDE | HIKMA FARMACEUTICA PORTUGAL SA | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 500MG BASE/VIAL | 2020/08/11 | N / N | DISCONTINUED | openFDA ↗ |
| A203300-002 | VANCOMYCIN HYDROCHLORIDE | HIKMA FARMACEUTICA PORTUGAL SA | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 1GM BASE/VIAL | 2020/08/11 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A204107-001 | VANCOMYCIN HYDROCHLORIDE | HIKMA PHARMACEUTICALS USA INC | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 500MG BASE/VIAL | 2015/12/28 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A204107-002 | VANCOMYCIN HYDROCHLORIDE | HIKMA PHARMACEUTICALS USA INC | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 1GM BASE/VIAL | 2015/12/28 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A204125-001 | VANCOMYCIN HYDROCHLORIDE | XELLIA PHARMACEUTICALS APS | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 5GM BASE/VIAL | 2015/12/28 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A204125-002 | VANCOMYCIN HYDROCHLORIDE | XELLIA PHARMACEUTICALS APS | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 10GM BASE/VIAL | 2015/12/28 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A204360-001 | VANCOMYCIN HYDROCHLORIDE | HIKMA FARMACEUTICA PORTUGAL SA | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 5GM BASE/VIAL | 2018/10/15 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A204360-002 | VANCOMYCIN HYDROCHLORIDE | HIKMA FARMACEUTICA PORTUGAL SA | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 10GM BASE/VIAL | 2018/10/15 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A205694-001 | VANCOMYCIN HYDROCHLORIDE | GLAND PHARMA LTD | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 500MG BASE/VIAL | 2016/01/21 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A205694-002 | VANCOMYCIN HYDROCHLORIDE | GLAND PHARMA LTD | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 1GM BASE/VIAL | 2016/01/21 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A205694-003 | VANCOMYCIN HYDROCHLORIDE | GLAND PHARMA LTD | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 5GM BASE/VIAL | 2023/06/06 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A205694-004 | VANCOMYCIN HYDROCHLORIDE | GLAND PHARMA LTD | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 10GM BASE/VIAL | 2023/06/06 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A205779-001 | VANCOMYCIN HYDROCHLORIDE | EUGIA PHARMA SPECIALITIES LTD | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 5GM BASE/VIAL | 2016/03/29 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A205779-002 | VANCOMYCIN HYDROCHLORIDE | EUGIA PHARMA SPECIALITIES LTD | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 10GM BASE/VIAL | 2016/03/29 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A205780-001 | VANCOMYCIN HYDROCHLORIDE | EUGIA PHARMA SPECIALITIES LTD | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 500MG BASE/VIAL | 2016/03/31 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A205780-002 | VANCOMYCIN HYDROCHLORIDE | EUGIA PHARMA SPECIALITIES LTD | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 1GM BASE/VIAL | 2016/03/31 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A206243-001 | VANCOMYCIN HYDROCHLORIDE | XELLIA PHARMACEUTICALS APS | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 5GM BASE/VIAL | 2015/12/23 | N / N | DISCONTINUED | openFDA ↗ |
| A206243-002 | VANCOMYCIN HYDROCHLORIDE | XELLIA PHARMACEUTICALS APS | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 10GM BASE/VIAL | 2015/12/23 | N / N | DISCONTINUED | openFDA ↗ |
| A206616-001 | VANCOMYCIN HYDROCHLORIDE | HIKMA PHARMACEUTICALS | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 750MG BASE/VIAL | 2018/10/03 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A212332-001 | VANCOMYCIN HYDROCHLORIDE | HAINAN POLY PHARM CO LTD | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 500MG BASE/VIAL | 2019/06/12 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A212332-002 | VANCOMYCIN HYDROCHLORIDE | HAINAN POLY PHARM CO LTD | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 1GM BASE/VIAL | 2019/06/12 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A213059-001 | VANCOMYCIN HYDROCHLORIDE | KNACK PHARMACEUTICALS INC | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 500MG BASE/VIAL | 2022/02/15 | N / N | DISCONTINUED | openFDA ↗ |
| A213059-002 | VANCOMYCIN HYDROCHLORIDE | KNACK PHARMACEUTICALS INC | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 750MG BASE/VIAL | 2022/02/15 | N / N | DISCONTINUED | openFDA ↗ |
| A213059-003 | VANCOMYCIN HYDROCHLORIDE | KNACK PHARMACEUTICALS INC | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 1GM BASE/VIAL | 2022/02/15 | N / N | DISCONTINUED | openFDA ↗ |
| A215195-001 | VANCOMYCIN HYDROCHLORIDE | MEITHEAL PHARMACEUTICALS INC | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 750MG BASE/VIAL | 2022/09/15 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A215196-001 | VANCOMYCIN HYDROCHLORIDE | MEITHEAL PHARMACEUTICALS INC | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 5GM BASE/VIAL | 2022/07/27 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A215196-002 | VANCOMYCIN HYDROCHLORIDE | MEITHEAL PHARMACEUTICALS INC | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 10GM BASE/VIAL | 2022/07/27 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A215197-001 | VANCOMYCIN HYDROCHLORIDE | MEITHEAL PHARMACEUTICALS INC | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 500MG BASE/VIAL | 2022/07/28 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A215197-002 | VANCOMYCIN HYDROCHLORIDE | MEITHEAL PHARMACEUTICALS INC | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 1GM BASE/VIAL | 2022/07/28 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A215821-001 | VANCOMYCIN HYDROCHLORIDE | HAINAN POLY PHARM CO LTD | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 5GM BASE/VIAL | 2021/11/18 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A215821-002 | VANCOMYCIN HYDROCHLORIDE | HAINAN POLY PHARM CO LTD | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 10GM BASE/VIAL | 2021/11/18 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A216591-001 | VANCOMYCIN HYDROCHLORIDE | ASPIRO PHARMA LTD | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 500MG BASE/VIAL | 2022/07/06 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
| A216591-002 | VANCOMYCIN HYDROCHLORIDE | ASPIRO PHARMA LTD | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE: EQ 1GM BASE/VIAL | 2022/07/06 | N / N | HUMAN PRESCRIPTION DRUG | openFDA ↗ |
Listed US patents
*PED rows, substance/product flags, use codes and delisting-request flags are retained without determining legal effect.
Latest listed patent expiration—
Substance patent expiration (DS flag)—
This column includes only source rows explicitly flagged DS. A PED row without that flag is not assigned one by this site.
| Application / product number | Patent number | Listed expiration | Substance / product flags | Use code | Delisting request | Official source |
|---|---|---|---|---|---|---|
| Not listed | ||||||
Exclusivity source records
FDA exclusivity code list ↗Latest exclusivity expiration: —
| Application / product number | Exclusivity code | Listed expiration | Official source |
|---|---|---|---|
| Not listed | |||
Chinese record details
Chinese product landscape ↗The four-zero filter applies only to matched rows: catalog holders, NHSA approval numbers, applications under review, and companies filing generics this year. Unmatched rows have no Chinese counts. Filings are counted by acceptance number and filing companies by first applicant. Strengths may have separate applications. Drug names are normalized only for width and whitespace; distinct generic names, dosage forms and combinations remain separate. Unstated strengths are marked. Company counts from different sources must not be added together.
Catalog holders 12
| Company (original) | Identifier (original) | Source date | Official source |
|---|---|---|---|
| Fu An Pharma Group Hubei Ren Min Pharmaceutical Co., Ltd. romanized | 国药准字H20265043See source | 2026/06/30 | Official source ↗ |
| Anhui Pioneer Pharmaceutical Co., Ltd | 国药准字H20264232See source | 2026/05/07 | Official source ↗ |
| NORTH CHINA PHARMACEUTICAL COMPANY.LTD | 国药准字H20255230See source | 2025/08/26 | Official source ↗ |
| Hainan Brilliant Pharmaceutical Co., Ltd. | 国药准字H20253781See source | 2025/04/01 | Official source ↗ |
| Shandong Lukang Pharmaceutical Co.,Ltd. | 国药准字H20244955See source | 2024/09/19 | Official source ↗ |
| Nanjing Heng Dao Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20244808See source | 2024/09/03 | Official source ↗ |
| Hainan Pu Li Pharmaceutical Co., Ltd. romanized | 国药准字H20243660See source | 2024/05/08 | Official source ↗ |
| Li Zhu Group Li Zhu Pharmaceutical Factory romanized | 国药准字H20193378See source | 2023/04/05 | Official source ↗ |
| Zhejiang Hai Zheng Pharma Co., Ltd. romanized | 国药准字H20084268See source | 2021/11/15 | Official source ↗ |
| Zhejiang Pharmaceuticals Co., Ltd. romanized | 国药准字H20033366See source | 2021/06/03 | Official source ↗ |
| VANCOCIN ITALIA S.R.L. | H20140174500mg | 1988/10/15 | Official source ↗ |
| YaoPharma Co., Ltd. | 国药准字H20254904See source | 2025/07/22 | Official source ↗ |
NHSA approval numbers 15
| Company (original) | Identifier (original) | Source date | Official source |
|---|---|---|---|
| Li Zhu Group Li Zhu Pharmaceutical Factory romanized | 国药准字H20193378See source | — | Official source ↗ |
| YaoPharma Co., Ltd. | 国药准字H20254904See source | — | Official source ↗ |
| NORTH CHINA PHARMACEUTICAL COMPANY.LTD | 国药准字H20255230See source | — | Official source ↗ |
| Anhui Pioneer Pharmaceutical Co., Ltd | 国药准字H20264232See source | — | Official source ↗ |
| Zhejiang Hai Zheng Pharma Co., Ltd. romanized | 国药准字H20084268See source | — | Official source ↗ |
| Zhejiang Pharmaceuticals Co., Ltd. Xin Chang Pharmaceutical Factory romanized | 国药准字H20033366See source | — | Official source ↗ |
| Hainan Brilliant Pharmaceutical Co., Ltd. | 国药准字H20253781See source | — | Official source ↗ |
| Hainan Pu Li Pharmaceutical Co., Ltd. romanized | 国药准字H20243660See source | — | Official source ↗ |
| Fu An Pharma Group Hubei Ren Min Pharmaceutical Co., Ltd. romanized | 国药准字H20265043See source | — | Official source ↗ |
| VANCOCIN ITALIA S.R.L. | 国药准字HJ20140174See source | — | Official source ↗ |
| CJ HealthCare Corporation | H20171132See source | — | Official source ↗ |
| Gentle pharma Co.,Ltd. | HC20150054See source | — | Official source ↗ |
| Nanjing Heng Dao Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20244808See source | — | Official source ↗ |
| Shandong Lukang Pharmaceutical Co.,Ltd. | 国药准字H20244955See source | — | Official source ↗ |
| Li Zhu Group Li Zhu Pharmaceutical Factory romanized | 国药准字H20193378See source | — | Official source ↗ |
| Anhui Pioneer Pharmaceutical Co., Ltd | 国药准字H20264232See source | — | Official source ↗ |
| Zhejiang Hai Zheng Pharma Co., Ltd. romanized | 国药准字H20084268See source | — | Official source ↗ |
| Hainan Brilliant Pharmaceutical Co., Ltd. | 国药准字H20253781See source | — | Official source ↗ |
| Hainan Pu Li Pharmaceutical Co., Ltd. romanized | 国药准字H20243660See source | — | Official source ↗ |
| Fu An Pharma Group Hubei Ren Min Pharmaceutical Co., Ltd. romanized | 国药准字H20265043See source | — | Official source ↗ |
| Gentle pharma Co.,Ltd. | HC20150054See source | — | Official source ↗ |
| Nanjing Heng Dao Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20244808See source | — | Official source ↗ |
| Nanjing Heng Dao Pharmaceuticals Technology Co., Ltd. romanized | 国药准字H20244808See source | — | Official source ↗ |
| Zhejiang Hai Zheng Pharma Co., Ltd. romanized | 国药准字H20084269See source | — | Official source ↗ |
| Zhejiang Hai Zheng Pharma Co., Ltd. romanized | 国药准字H20084269See source | — | Official source ↗ |
Under review 4
| Company (original) | Identifier (original) | Source date | Official source |
|---|---|---|---|
| Nanjing Hai Na Pharmaceutical Co., Ltd. romanized | CYHS2600957 | 2026/04/24 | Official source ↗ |
| Yi Teng Pharmaceuticals (Zhuhai) Co., Ltd. romanized; Nanjing Jian You Sheng Hua Pharmaceutical Co., Ltd. romanized | CYHS2600726 | 2026/03/26 | Official source ↗ |
| Shenzhen Li Jian Pharma Co., Ltd. romanized | CYHS2601766 | 2026/07/23 | Official source ↗ |
| Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CYHS2600636 | 2026/03/10 | Official source ↗ |
Generic-filing companies this year 4
| Company (original) | Identifier (original) | Source date | Official source |
|---|---|---|---|
| Nanjing Hai Na Pharmaceutical Co., Ltd. romanized | CYHS2600957 | 2026/04/24 | Official source ↗ |
| Yi Teng Pharmaceuticals (Zhuhai) Co., Ltd. romanized; Nanjing Jian You Sheng Hua Pharmaceutical Co., Ltd. romanized | CYHS2600726 | 2026/03/26 | Official source ↗ |
| Shenzhen Li Jian Pharma Co., Ltd. romanized | CYHS2601766 | 2026/07/23 | Official source ↗ |
| Shijiazhuang No.4 Pharmaceutical Co., Ltd. | CYHS2600636 | 2026/03/10 | Official source ↗ |
API companies with A status 6
| Company (original) | Identifier (original) | Source date | Official source |
|---|---|---|---|
| Zhejiang Chang Hai Pharmaceutical Co., Ltd. romanized | Y20230000281 | 2025/03/06 | Official source ↗ |
| Zhejiang Pharmaceuticals Co., Ltd. Xin Chang Pharmaceutical Factory romanized | Y20190009487 | — | Official source ↗ |
| Hua Bei Pharmaceutical Hua Sheng Co., Ltd. romanized | Y20190006976 | — | Official source ↗ |
| Zhejiang Hai Zheng Pharma Co., Ltd. romanized | Y20190006263 | 2025/07/04 | Official source ↗ |
| Zhejiang Pharmaceuticals Co., Ltd. Xin Chang Pharmaceutical Factory romanized | Y20180001287 | 2025/03/18 | Official source ↗ |
| Li Zhu Group Fuzhou Fu Xing Pharmaceuticals Co., Ltd. romanized | Y20170000276 | 2026/09/03 | Official source ↗ |
| Ya Sai Li (Tai Zhou) Pharmaceutical Co., Ltd. romanized | Y20170000173 | 2024/10/22 | Official source ↗ |
Trial registrations 2025/2026 —
Not loaded
Sources and dates
- FDA Orange Book
- 2026/11/06
- CDE acceptance and review
- 2026/11/13 06:42
- Chemical Drug Catalog
- 2026/11/13 06:39
- API registration records
- 2026/11/13 06:41
- NHSA drug code database
- 2026/10/23
- Trial registry
- 2026/11/13 08:09 · Incomplete coverage
Chinese counts use complete ingredient, dosage-form and route matches. Unmatched and partial rows show name-source matching only and make no finding about Chinese approvals or filings. Trials cover registration-number years 2025/2026 only.
Formulation crosswalk to INJECTABLE / INJECTION, based on the Chinese Pharmacopoeia general formulation provisions, rule CHP-FORM-088. Chinese Pharmacopoeia general chapter 0102
Comparison generated: 2026/11/13 18:41 · openFDA Orange Book ↗
Name and dosage-form matching sources
- NMPA reference-product directory, Shaanxi MPA republication ↗ · 26-90 · 2020/06/04
- Chinese Pharmacopoeia 2025, formulation chapter; site crosswalk ↗ · See source
Subscriptions
Next-day facts and deliverable timelines
- One email the next day when new facts are collected for your followed products.
- Export the complete loaded event timeline for each followed product as CSV.
- Add up to 4 additional recipients, each confirmed by email.
- Increase your follow limit from 3 to 10 products.
Quarterly
US$540
Billed every three months
US$180 per month
Sign in to subscribeYearly
US$1,920
Billed every year
US$160 per month
Sign in to subscribeNeed more than 10 followed products or more than 5 recipients? Contact us.
Separate one-time purchase
US Orange Book × China records comparison
Full table and CSV export for 12 months from payment, with monthly data updates. No automatic renewal.
Subscriptions and comparison-table access are purchased separately. Neither includes the other.
Billed by Creem, our merchant of record · Terms · Refund policy